SARS-CoV-2 viral dynamics in non-human primates
- PMID: 33730053
- PMCID: PMC8007039
- DOI: 10.1371/journal.pcbi.1008785
SARS-CoV-2 viral dynamics in non-human primates
Abstract
Non-human primates infected with SARS-CoV-2 exhibit mild clinical signs. Here we used a mathematical model to characterize in detail the viral dynamics in 31 cynomolgus macaques for which nasopharyngeal and tracheal viral load were frequently assessed. We identified that infected cells had a large burst size (>104 virus) and a within-host reproductive basic number of approximately 6 and 4 in nasopharyngeal and tracheal compartment, respectively. After peak viral load, infected cells were rapidly lost with a half-life of 9 hours, with no significant association between cytokine elevation and clearance, leading to a median time to viral clearance of 10 days, consistent with observations in mild human infections. Given these parameter estimates, we predict that a prophylactic treatment blocking 90% of viral production or viral infection could prevent viral growth. In conclusion, our results provide estimates of SARS-CoV-2 viral kinetic parameters in an experimental model of mild infection and they provide means to assess the efficacy of future antiviral treatments.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: A.G. PhD grant has been provided by ROCHE Company. J.G. has worked as consultant for ROCHE Company.
Figures






References
-
- Weekly epidemiological update—22 December 2020. [cited 11 Jan 2021]. Available: https://www.who.int/publications/m/item/weekly-epidemiological-update—22...
-
- Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al.. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020;8: 475–481. 10.1016/S2213-2600(20)30079-5 - DOI - PMC - PubMed
-
- Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S, et al.. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv. 2020. [cited 2 Jun 2020]. 10.1101/2020.03.30.20047365 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous